Search research articles
Contact Us
Filters
Showing results (51-60 of 138) with videos related to
Page
of 14
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 17, 2020
Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial
James Posada, Saba Valadkhan, Daniel Burge, et al.
Rheumatology (Oxford, England)
|
April 3, 2018
B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome
Katherine James, Chimwemwe Chipeta, Antony Parker, et al.
Scientific Reports
|
March 1, 2019
MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants
Marianne Venter, Cara Tomas, Ilse S Pienaar, et al.
NPJ Systems Biology and Applications
|
March 28, 2026
The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms
Sacha E Silva-Saffar, Xavier Mariette, Jacques-Eric Gottenberg, et al.
Digital Health
|
June 26, 2023
Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study
Johanna Graeber, Elke Warmerdam, Svenja Aufenberg, et al.
Medicine
|
June 27, 2020
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
Stefan Siebert, Arthur G Pratt, Deborah D Stocken, et al.
JMIR Human Factors
|
April 30, 2026
Technology Acceptance of 2 mHealth Apps During an Observational Technology Evaluation Study: Qualitative Results of a Mixed Methods Study
Johanna Graeber, Elke Warmerdam, Svenja Aufenberg, et al.
BMC Medical Genetics
|
March 18, 2017
Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome
Elizna M Schoeman, Francois H Van Der Westhuizen, Elardus Erasmus, et al.
Rheumatology International
|
January 4, 2019
Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial
Samira Tatiyama Miyamoto, Valéria Valim, Luciana Carletti, et al.
Nature Medicine
|
June 5, 2024
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
E William St Clair, Alan N Baer, Wan-Fai Ng, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 138) with videos related to
Sort By:
Page
of 14
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 17, 2020
Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial
James Posada, Saba Valadkhan, Daniel Burge, et al.
Rheumatology (Oxford, England)
|
April 3, 2018
B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome
Katherine James, Chimwemwe Chipeta, Antony Parker, et al.
Scientific Reports
|
March 1, 2019
MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants
Marianne Venter, Cara Tomas, Ilse S Pienaar, et al.
NPJ Systems Biology and Applications
|
March 28, 2026
The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms
Sacha E Silva-Saffar, Xavier Mariette, Jacques-Eric Gottenberg, et al.
Digital Health
|
June 26, 2023
Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study
Johanna Graeber, Elke Warmerdam, Svenja Aufenberg, et al.
Medicine
|
June 27, 2020
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
Stefan Siebert, Arthur G Pratt, Deborah D Stocken, et al.
JMIR Human Factors
|
April 30, 2026
Technology Acceptance of 2 mHealth Apps During an Observational Technology Evaluation Study: Qualitative Results of a Mixed Methods Study
Johanna Graeber, Elke Warmerdam, Svenja Aufenberg, et al.
BMC Medical Genetics
|
March 18, 2017
Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome
Elizna M Schoeman, Francois H Van Der Westhuizen, Elardus Erasmus, et al.
Rheumatology International
|
January 4, 2019
Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial
Samira Tatiyama Miyamoto, Valéria Valim, Luciana Carletti, et al.
Nature Medicine
|
June 5, 2024
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
E William St Clair, Alan N Baer, Wan-Fai Ng, et al.
Page
of 14